Hologic Showcases Comprehensive Breast and Skeletal Health Solutions at RSNA 2022
By MedImaging International staff writers Posted on 29 Nov 2022 |
Hologic, Inc. (Marlborough, MA, USA) is exhibiting its extensive portfolio of breast and skeletal health products at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 27 to Dec. 1. Among the full suite of breast biopsy and surgery solutions are Hologic’s Affirm Contrast Biopsy software, which is on display for the first time since becoming commercially available in the U.S.
Affirm Contrast Biopsy software allows clinicians to target and acquire tissue samples in lesions identified with I-View Contrast-Enhanced Mammography software. The contrast solution provides healthcare facilities with a viable and attractive alternative to breast MRI, which historically has been used to find and biopsy more elusive lesions, such as those that cannot be seen via mammography or ultrasound. While breast MRI can be time-consuming and costly, contrast technology gives radiologists another option in the mammography suite that addresses these shortcomings. In a recent clinical study, 98% of patients had an overall positive opinion of their procedure experience with Affirm Contrast Biopsy software.
RSNA attendees can experience Hologic’s portfolio at Booth 1911 in South Hall Level 3 at McCormick Place in Chicago. In addition to the AffirmContrast Biopsy software, Hologic is featuring its Dimensions mammography portfolio and Supersonic MACH ultrasound systems. Hologic is also hosting a series of CME- and non-CME-accredited medical education symposiums and learning opportunities, accessible to attendees on-site and from remote locations.
“As the global leader in breast imaging, we are committed to addressing the unmet needs of physicians and their patients across the continuum of breast care and we’re eager to engage with industry leaders at this year’s RSNA meeting to share our vision for the future of breast health,” said Erik Anderson, President of Hologic’s Breast and Skeletal Health Solutions Division. “We are equally excited to showcase our new Affirm Contrast Biopsy technology, which is a great example of our commitment to physicians and patients in action.”
Related Links:
Hologic, Inc.
Latest RSNA 2022 News
- Vieworks Exhibits Complete Lineup of Next Generation X-Ray Flat Panel Detectors at RSNA 2022
- Subtle Medical Showcases AI-Powered Imaging Workflow Solutions at RSNA 2022
- PaxeraHealth Demonstrates the Latest in Artificial Intelligence Technology for Imaging at RSNA 2022
- Varex Presents Advances in X-Ray Technology at RSNA 2022
- Radcal Demonstrates Accu-Gold TOUCH Series for X-Ray QA and Service at RSNA 2022
- Agfa Showcases Groundbreaking, Intelligent Solutions That Empower X-Ray Experts at RSNA 2022
- Philips Demonstrates Smart Connected Imaging and Integrated Workflow Solutions at RSNA 2022
- Bayer Highlights Radiology Portfolio and Innovation in AI at RSNA 2022
- Canon Showcases Meaningful Innovation in its Suite of Solutions and Products at RSNA 2022
- Mindray Debuts New Ultrasound Systems and Hepatology Solutions at RSNA 2022
- Siemens Presents Revolutionary High-End MRI Scanners at RSNA 2022
- 4DMedical Debuts Most Advanced Lung Scanning Technology in Decades at RSNA 2022
- KA Imaging Unveils World’s First Integrated Mobile X-Ray System with Dual-Energy Capabilities at RSNA 2022
- AIRS Medical Showcases Award-Winning MRI Enhancement AI Solution at RSNA 2022
- Alpinion Presents New Range of High-Performance Diagnostic Equipment at RSNA 2022
- Fujifilm Unveils New Medical Imaging Advances at RSNA 2022